Oncology
Thomas Gajewski, MD
AbbVie Foundation Professor in Cancer Immunotherapy; Professor of Ben May Department of Cancer Research; Director, Melanoma Program; Professor, Medicine, The University of Chicago Pritzker School of Medicine
Thomas F. Gajewski, MD, PhD, is a board-certified medical oncologist specializing in melanoma at the University of Chicago Medical Center. His clinical practice focuses on treating patients with advanced melanoma using innovative immunotherapies, including TIL (tumor-infiltrating lymphocyte) therapy and checkpoint blockade therapies targeting PD-1, CTLA-4, and LAG-3. Dr. Gajewski leads the development of immune-based treatments for melanoma and other solid tumors, drawing from laboratory researc
35+
Years in Practice
Credentials
Board Certifications
- Medical Oncology
Education & Training
- The University of Chicago Pritzker School of Medicine — M.D., 1991
- The University of Chicago — Ph.D., Immunology
- The University of Chicago — B.S.
- University of Chicago Medicine — Fellowship, Hematology/Oncology
- University of Chicago Medicine — Residency, Internal Medicine
Peer Recognition
- Castle Connolly — Top Doctor
2017-2026 (10 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- UChicago Medicine - University of Chicago Medical Center
Languages
English
Experience
35+ years in practice